Hengrui weighs Hong Kong IPO to drive the next phase of global expansion
A Hong Kong listing rarely boosts Chinese firms’ valuations, but Hengrui Pharmaceuticals might still take the plunge. The post Hengrui...
36Kr English
A Hong Kong listing rarely boosts Chinese firms’ valuations, but Hengrui Pharmaceuticals might still take the plunge. The post Hengrui...
